Showing results (1-10 of 111) with videos related to

Sort By:
Pageof 12
American Journal of Clinical Pathology|October 23, 2003
Expression of anaplastic lymphoma kinase in non-Hodgkin's lymphomas and other malignant neoplasms. Biological, diagnostic, and clinical implicationsMariusz A Wasik
Advances in Cancer Research & Clinical Imaging : ACRCI|August 20, 2024
Emerging Role of Functional Magnetic Resonance Spectroscopy (MRS) to Monitor Response to Kinase Inhibitors in CancerKavindra Nath, Pradeep K Gupta, Mariusz A Wasik
Frontiers in Oncology|April 19, 2024
Diverse and reprogrammable mechanisms of malignant cell transformation in lymphocytes: pathogenetic insights and translational implicationsMariusz A Wasik, Patricia M Kim, Reza Nejati
Cancers|October 17, 2017
From Pathology to Precision Medicine in Anaplastic Large Cell Lymphoma Expressing Anaplastic Lymphoma Kinase (ALK+ ALCL)Michael T Werner, Qian Zhang, Mariusz A Wasik
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|May 22, 2013
Targeting CD30 in malignant tissues: challenges in detection and clinical applicationsMariusz A Wasik, Gretchen S Jimenez, Dennis D Weisenburger
Nature Medicine|October 9, 2007
STAT5A is epigenetically silenced by the tyrosine kinase NPM1-ALK and acts as a tumor suppressor by reciprocally inhibiting NPM1-ALK expressionQian Zhang, Hong Y Wang, Xiaobin Liu, et al.
Blood|November 24, 2016
Nucleophosmin-anaplastic lymphoma kinase: the ultimate oncogene and therapeutic targetMichael T Werner, Chen Zhao, Qian Zhang, et al.
Cancer Biology & Therapy|January 13, 2012
The role of cytokine signaling in the pathogenesis of cutaneous T-cell lymphomaRonnie M Abraham, Qian Zhang, Niels Odum, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 13, 2006
Nucleophosmin/anaplastic lymphoma kinase (NPM/ALK) oncoprotein induces the T regulatory cell phenotype by activating STAT3Monika Kasprzycka, Michal Marzec, Xiaobin Liu, et al.
Archives of Pathology & Laboratory Medicine|March 26, 2003
Natural killer-like T-cell lymphoma of the small intestine with a distinct immunophenotype and lack of association with gluten-sensitive enteropathyConstance M Yuan, Steven Stein, John H Glick, et al.
Pageof 12